Smith & Nephew (SNN) Total Current Liabilities (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Total Current Liabilities of $1.6 billion for Q4 2025, up 4.18% year-on-year from $1.5 billion in Q4 2024, and up 4.18% on a QoQ basis from $1.5 billion in Q4 2024.
Smith & Nephew (SNN) Total Current Liabilities (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Total Current Liabilities for 17 consecutive years, with $1.6 billion the latest figure, recorded in Q4 2025.
- Quarterly Total Current Liabilities rose 4.18% year-over-year to $1.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 billion (up 4.18% YoY) and the FY2025 annual result came in at $1.6 billion, up 4.18% from the prior year.
- Total Current Liabilities improved to $1.6 billion in Q4 2025 per SNN's latest filing, from $1.5 billion in the prior quarter.
- Over the last five years, Total Current Liabilities for SNN reached as high as $2.3 billion in Q4 2023 and fell as low as $1.5 billion in Q4 2024.
- A 5-year average of $1.8 billion and a median of $1.7 billion in 2022 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Current Liabilities surged 32.42% — and 2024, when it sank 32.58%.
- Year by year, Total Current Liabilities stood at $2.1 billion in 2021, then fell by 19.52% to $1.7 billion in 2022, then jumped by 32.42% to $2.3 billion in 2023, then sank by 32.58% to $1.5 billion in 2024, then gained by 4.18% to $1.6 billion in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $1.6 billion, $1.5 billion, and $2.3 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 1.15 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.60 Bn |
| Dec 31, 2024 | 1.53 Bn |
| Dec 31, 2023 | 2.27 Bn |
| Dec 31, 2022 | 1.72 Bn |
| Dec 31, 2021 | 2.13 Bn |
| Dec 31, 2020 | 1.69 Bn |
| Dec 31, 2019 | 1.56 Bn |
| Dec 31, 2018 | 1.47 Bn |
| Dec 31, 2017 | 1.35 Bn |
| Dec 31, 2016 | 1.35 Bn |
| Dec 31, 2015 | 1.34 Bn |
| Jun 30, 2015 | 1.23 Bn |
| Dec 31, 2014 | 1.16 Bn |
| Jun 28, 2014 | 1.15 Bn |
| Mar 31, 2014 | 1.06 Bn |
| Dec 31, 2013 | 1.07 Bn |
| Sep 28, 2013 | 3.40 Bn |
| Mar 31, 2013 | 916.00 Mn |
| Dec 31, 2012 | 930.00 Mn |
| Sep 29, 2012 | 908.00 Mn |